uterine carcinosarcoma
Showing 1 - 25 of 1,792
Ovarian Carcinosarcoma, Uterine Carcinosarcoma Trial (Eribulin Mesylate, Pembrolizumab)
Not yet recruiting
- Ovarian Carcinosarcoma
- Uterine Carcinosarcoma
- Eribulin Mesylate
- Pembrolizumab
- (no location specified)
Jan 31, 2023
Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma Trial in United States (Pembrolizumab, Lenvatinib)
Recruiting
- Uterine Carcinosarcoma
- Advanced Uterine Carcinosarcoma
-
Basking Ridge, New Jersey
- +6 more
Apr 27, 2022
Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)
Not yet recruiting
- Gynecologic Cancer
- +3 more
- Cabo + Dostarlimab
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Carcinosarcoma, Ovarian, Carcinosarcomas Uterine Trial in Rome (Trabectedin)
Completed
- Carcinosarcoma, Ovarian
- Carcinosarcomas Uterine
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Aug 24, 2021
Liquid Biopsies and Tumor Molecular Profiling in Predicting
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +5 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
- Uterine Carcinosarcoma
- Rucaparib
- +2 more
-
New York, New York
- +2 more
Apr 4, 2022
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)
Terminated
- Stage IA Uterine Sarcoma
- +10 more
- paclitaxel
- +5 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Apr 21, 2021
Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin
Active, not recruiting
- Breast Carcinoma
- +4 more
- Metformin Hydrochloride
- Doxycycline
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 28, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)
Active, not recruiting
- Uterine Cancer
- +6 more
-
Basking Ridge, New Jersey
- +7 more
Apr 4, 2022
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in
Active, not recruiting
- Endometrial Adenosquamous Carcinoma
- +9 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +18 more
Oct 15, 2022
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Leiomyosarcoma or Carcinosarcoma Trial in Germany (Pazopanib plus Gemcitabine, Pazopanib)
Recruiting
- Leiomyosarcoma or Carcinosarcoma
- Pazopanib plus Gemcitabine
- Pazopanib
-
Bad Saarow, Germany
- +8 more
Nov 27, 2020
Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)
Terminated
- Leiomyosarcoma
- +2 more
- Vorinostat Oral Capsule
-
Graz, AustriaMedical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020
Endometrioid Adenocarcinoma, Serous Carcinoma, Clear Cell Carcinoma Trial in London (Image-guided adjuvant pelvic radiotherapy)
Recruiting
- Endometrioid Adenocarcinoma
- +4 more
- Image-guided adjuvant pelvic radiotherapy
-
London, Ontario, CanadaLondon Regional Cancer Program
Sep 2, 2020
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Laboratory Biomarker Analysis
- Thalidomide
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Canada, United
Completed
- Endometrial Adenocarcinoma
- +7 more
- Sunitinib Malate
-
Beverly Hills, California
- +28 more
Feb 14, 2020